Trasis’ mission is to contribute to the improvement of healthcare by accelerating the introduction and use of the widest range of diagnostic and therapeutic agents.

To this end, our quality approach places our customers and their patients at the center of our concerns and aims to ensure the consistency and efficiency of our organization. It is accompanied by a systematic desire to move forward in order to guarantee the best quality of products and services. This approach contributes to customer loyalty by offering them the reliable partner they need.
In this sense, Trasis SA implements a Quality System by integrating in a single organization all the standards / regulations in line with the requirements of the various fields of activity and the various products.

Concretely,

Our QMS (Quality Management System) is based on the ISO 9001:2015 certification.
We have 2 distribution authorizations issued by the Belgian Federal Agency for Medicines and Health Products (AFMPS) concerning medical devices and active substances.
We have obtained the following 2 GMP certificates from the Belgian Federal Agency for Medicines and Health Products (AFMPS):
– GMP Part I – Human Medicinal Product – Authorization 2029 H for the manufacture of sterile medicines and associated quality control operations.
– GMP Part II – Active Substance – for the manufacture of active substances by chemical synthesis and associated quality control operations.

GDP Good Distribution Practices training | Smart Global College and Academy

Certifications